DEXTROSE 50% Drug Patent Profile
✉ Email this page to a colleague
When do Dextrose 50% patents expire, and what generic alternatives are available?
Dextrose 50% is a drug marketed by Hospira, Intl Medication Sys, Baxter Hlthcare, and Icu Medical Inc. and is included in six NDAs.
The generic ingredient in DEXTROSE 50% is dextrose. There are nine drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the dextrose profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEXTROSE 50%?
- What are the global sales for DEXTROSE 50%?
- What is Average Wholesale Price for DEXTROSE 50%?
Summary for DEXTROSE 50%
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 9 |
| DailyMed Link: | DEXTROSE 50% at DailyMed |
US Patents and Regulatory Information for DEXTROSE 50%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | DEXTROSE 50% | dextrose | INJECTABLE;INJECTION | 019445-001 | Jun 3, 1986 | AP | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Baxter Hlthcare | DEXTROSE 50% IN PLASTIC CONTAINER | dextrose | INJECTABLE;INJECTION | 020047-001 | Jul 2, 1991 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Intl Medication Sys | DEXTROSE 50% | dextrose | INJECTABLE;INJECTION | 203451-001 | Mar 26, 2021 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Baxter Hlthcare | DEXTROSE 50% IN PLASTIC CONTAINER | dextrose | INJECTABLE;INJECTION | 017521-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Icu Medical Inc | DEXTROSE 50% IN PLASTIC CONTAINER | dextrose | INJECTABLE;INJECTION | 019894-001 | Dec 26, 1989 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
